Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Tczew

5 clinical trials in Tczew, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Tczew at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Tczew

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Chronic kidney disease+1

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Tczew

What the registry says about research in the country

01 Nephrology & Cardiovascular Research

Innovative research focusing on the intersection of chronic kidney disease (CKD) and hypertension management, evaluating combination therapies to improve patient outcomes.

  • Kidney Function Assessment
  • Blood Pressure Management
  • Disease Progression Prevention

Studies aim to evaluate novel therapeutic approaches for slowing CKD progression while managing cardiovascular complications.

02 End-Stage Kidney Disease Research

Clinical investigations examining treatment options for patients with end-stage kidney disease (ESKD) undergoing dialysis, with a focus on cardiovascular complications.

  • Dialysis Patient Care
  • Inflammatory Markers
  • Cardiovascular Risk Management

Research centered on reducing inflammation markers and improving cardiovascular outcomes in dialysis patients.

03 Cardiovascular Therapeutics

Studies evaluating the effectiveness of combined therapeutic approaches in managing atherosclerotic cardiovascular disease in patients with kidney conditions.

  • Combination Drug Therapy
  • Clinical Outcomes Assessment
  • Safety Profile Evaluation

Focuses on developing comprehensive treatment strategies for complex cardio-renal conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.